Maddox Pharma Swiss ApS
CVR 44714922 · Private limited company (ApS) · Active · Very high risk
Maddox Pharma Swiss ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 11.5% over the next 12 months, which is 8.2 times the average for Danish companies. 2 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -51k and a net result of DKK -140k. CEO: Gesor Ramona Kissling, Diego Pesciatini, Anna Maria Izydorczyk-Spus.
Bankruptcy risk for Maddox Pharma Swiss ApS
8.2 × the average (1.41%) · higher risk than 97% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44714922
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Amager Strandvej 60
2300 København S - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- Ecovis Danmark
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -45.5% |
| Current ratio | 69% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 63 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -125k | DKK 69k |
| Net profit | DKK -140k | DKK 49k |
| Equity | DKK -51k | DKK 89k |
| Total assets | DKK 112k | DKK 118k |
| Cash | DKK 16k | – |
| Short-term debt | DKK 163k | – |
| Tax owed | DKK 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Ecovis Danmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 189 | Late | |
| 14 Mar 2024 – 31 Dec 2024 | 198 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Gesor Ramona Kissling | Current | |
| CEO | Diego Pesciatini | Current | |
| CEO | Anna Maria Izydorczyk-Spus | Current | |
| Owner (100%) | Maddox Pharma Swiss GmbH | Current | |
| Founder | Maddox Pharma Swiss GmbH | Current |
Address history (1 moves)
| Amager Strandvej 60, 2300 København S | |
| c/o Ecovis Denmark, Vendersgade 28, st., 1363 København K |
Other companies at the same address
- (4S advisory ApS) Bankrupt
- Bostan Law ApS Bankrupt
- Co-operation Team IVS Bankrupt
- Energifacader 2020 ApS Bankrupt
- Grønt Arbejde & Entreprise ApS Bankrupt
- HY Trading ApS Bankrupt
- NN LIGHTING ApS Bankrupt
- Resource Holding ApS Bankrupt
- Vincenty Holding ApS Bankrupt
- Wiz service & management ApS Bankrupt
- AF Consult ApS Active
- AFRICA JOINT VENTURE HOLDING A/S Fusioneret
- ALIGHT General Partner ApS Active
- ANB 2020 Holding ApS Active
- Advension ApS Active
- Alight BidCo ApS Active
- Alight Hedgehog Midco ApS Active
- Alight Holding Denmark ApS Active
- Aurora Advokatfirma ApS Active
- BIOCORRECTION A/S Active
- Byggeri-fabrikken ApS Active
- CARECOMPAGNIET ApS Active
- Celco 2019 Holding ApS Active
- Celco Fliseentreprise ApS Active
- Celco Handel & Håndværk ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Gefjon Pharma ApS København N
- Linker Pharmaceuticals ApS København K
Questions and answers about Maddox Pharma Swiss ApS
Has Maddox Pharma Swiss ApS gone bankrupt?
No, Maddox Pharma Swiss ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Maddox Pharma Swiss ApS?
Our model estimates a bankruptcy risk of 11.5% over the next 12 months (very high risk), which is 8.2 times the average for Danish companies.
Who is the CEO of Maddox Pharma Swiss ApS?
Gesor Ramona Kissling, Diego Pesciatini, Anna Maria Izydorczyk-Spus are the CEOs of Maddox Pharma Swiss ApS.
Who is the auditor of Maddox Pharma Swiss ApS?
Maddox Pharma Swiss ApS most recently used Ecovis Danmark.
When was Maddox Pharma Swiss ApS founded?
Maddox Pharma Swiss ApS was founded on 14 March 2024.
What is the equity of Maddox Pharma Swiss ApS?
Equity was DKK -51k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.